Hyperion DeFi (NASDAQ:HYPD) Posts Earnings Results

by · The Cerbat Gem

Hyperion DeFi (NASDAQ:HYPD – Get Free Report) announced its earnings results on Thursday. The company reported $0.26 earnings per share for the quarter, FiscalAI reports. The firm had revenue of $0.24 million for the quarter.

Hyperion DeFi Price Performance

Hyperion DeFi stock traded up $0.12 during mid-day trading on Thursday, reaching $3.62. 782,467 shares of the company were exchanged, compared to its average volume of 503,883. The company has a fifty day simple moving average of $3.62 and a 200-day simple moving average of $3.90. Hyperion DeFi has a 12 month low of $1.08 and a 12 month high of $17.18. The company has a debt-to-equity ratio of 0.19, a current ratio of 2.68 and a quick ratio of 2.68. The firm has a market cap of $44.24 million, a PE ratio of -0.31 and a beta of 2.57.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of Hyperion DeFi in a research note on Thursday, January 22nd. Cantor Fitzgerald upgraded Hyperion DeFi to a “strong-buy” rating in a research note on Thursday, April 9th. Finally, Zacks Research lowered Hyperion DeFi from a “hold” rating to a “strong sell” rating in a research note on Monday, March 30th. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $5.88.

Check Out Our Latest Stock Analysis on Hyperion DeFi

Institutional Trading of Hyperion DeFi

Institutional investors and hedge funds have recently made changes to their positions in the company. Sanctuary Advisors LLC bought a new stake in shares of Hyperion DeFi during the 4th quarter worth approximately $38,000. Nations Financial Group Inc. IA ADV bought a new position in shares of Hyperion DeFi in the 4th quarter valued at $40,000. Price T Rowe Associates Inc. MD bought a new position in shares of Hyperion DeFi in the 4th quarter valued at $73,000. Formidable Asset Management LLC bought a new position in shares of Hyperion DeFi in the 4th quarter valued at $83,000. Finally, State Street Corp bought a new position in shares of Hyperion DeFi in the 4th quarter valued at $92,000. Institutional investors own 25.84% of the company’s stock.

Hyperion DeFi Company Profile

(Get Free Report)

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.

Further Reading